TAE Life Sciences Revenue and Competitors

Foothill Ranch,

Location

$70M

Total Funding

Estimated Revenue & Valuation

  • TAE Life Sciences's estimated annual revenue is currently $21.1M per year.(i)
  • TAE Life Sciences's estimated revenue per employee is $270,000
  • TAE Life Sciences's total funding is $70M.

Employee Data

  • TAE Life Sciences has 78 Employees.(i)
  • TAE Life Sciences grew their employee count by 28% last year.

TAE Life Sciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Science OfficerReveal Email/Phone
3
Global VP Marketing and StrategyReveal Email/Phone
4
VP Business Development, EMEAReveal Email/Phone
5
VP Business Development EMEAReveal Email/Phone
6
Director Software EngineeringReveal Email/Phone
7
Director, Molecular BiologyReveal Email/Phone
8
Senior Director Protein SciencesReveal Email/Phone
9
Director, Bioconjugation TechnologiesReveal Email/Phone
10
Director, Quality and ComplianceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.5M1978%N/AN/A
#2
$20.5M763%N/AN/A
#3
$202.5M60026%N/AN/A
#4
$44.8M1515%N/AN/A
#5
$34M1264%N/AN/A
#6
$34.8M1295%N/AN/A
#7
$42.8M14431%N/AN/A
#8
$16.2M69-22%$29.7MN/A
#9
$2131.5M563910%$9.3MN/A
#10
$56.4M19018%N/AN/A
Add Company

What Is TAE Life Sciences?

State-of-the-art biotechnology company enabling convenient clinical access to Boron Neutron Capture Therapy (BNCT), a promising, previously inaccessible cancer treatment.

keywords:N/A

$70M

Total Funding

78

Number of Employees

$21.1M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TAE Life Sciences News

2020-06-03 - TAE Life Sciences Finds $30M In Series B Round

Foothill Ranch-based TAE Life Sciences, which is developing boron-based radiation therapy drugs for the treatment of cancer, has raised $30M in what it says is an initial, Series B funding round. The company said the funding comes from a consortium of investors, including ARTIS Ventures. The com ...

2020-06-02 - TAE Life Sciences Raises $30M in Initial Series B Funding

Tae Life Sciences, a Foothill Ranch, Calif.-based biological-targeting radiation therapy company developing boron neutron capture therapy solutions, raised $30M in funding. The initial phase of the B-round funds come from a consortium of investors including Artis Ventures, who led the company’s ...

2018-03-12 - TAE Life Sciences Raises $40M in Venture Capital Funding

TAE Life Sciences, a Foothill Ranch, CA-based medical technology company developing an accelerator-based platform for clinical investigation of a promising, previously inaccessible cancer treatment, raised $40m in venture capital funding. The round was led by Artis Ventures. TAE Life Sciences, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.7M81-2%N/A
#2
$17.9M85-1%N/A
#3
$15.8M99607%N/A
#4
$22.7M10811%N/A
#5
$26.3M1253%N/A